study_title: B.1.1.529 escapes the majority of SARS-CoV-2 neutralizing antibodies of diverse epitopes
study_first_author: Cao
study_year: 2022
study_journal: Nature
study_url: https://www.nature.com/articles/s41586-021-04385-3
lab: Xie_XS
notes: data from Y. Cao by e-mail
conditions:
  BD-739:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: vaccine
  BRII-196:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41467-020-20501-9
    alias: amubarvimab
  C093:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-021-03207-w
  COVOX-150:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2021.02.032
  BD-822:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  BD-715:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: vaccine
  COVA2-04:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1126/science.abc5902
  CV30:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.immuni.2020.06.001
  BD-503:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD55-1374:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  BD55-1789:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  BD-693:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: vaccine
  BD-694:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: vaccine
  C105:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-020-2456-9
  C1A-B12:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2021.03.027
  C1A-B3:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2021.03.027
  C1A-C2:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2021.03.027
  C1A-F10:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2021.03.027
  LY-CoV016:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-020-2381-y
    alias: etesevimab
  CC12.1:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1126/science.abd2321
  CC12.3:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1126/science.abd2321
  COV2-2807:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  DH1154:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  DH1179:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  DH1210:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  LY-CoV481:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1126/scitranslmed.abf1906
  LY-CoV488:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1126/scitranslmed.abf1906
  P2B-1A10:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41422-021-00487-9
  P4A1:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41467-021-22926-2
  P5A-3A1:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41422-021-00487-9
  B38:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1126/science.abc2241
  BD-236:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD-498:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD-500:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD-508:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD-598:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD-599:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD-605:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD-619:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD-915:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: vaccine
  BD-930:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: vaccine
  C102:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-020-2456-9
  C578:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-021-03207-w
  COV2-2113:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  COV2-2589:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  COV2-2919:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  COVOX-269:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2021.02.032
  COVOX-88:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2021.02.032
  DH1126:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  DH1140:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  Ehling_mAb-64:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2021.02.12.430940
  P5A-2G9:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41422-021-00487-9
  BD-504:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD-616:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD55-1763:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  COV2-2308:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1038/s41591-020-0998-x
  COV2-2098:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  BD-612:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: short-term convalescent
  WIBP-2B11:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41421-021-00295-w
  BD-614:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: short-term convalescent
  COVOX-222:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1016/j.cell.2021.02.032
  BD-618:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: short-term convalescent
  BD55-5293:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: SARS convalescent
  DXP-604:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: short-term convalescent
  BD-369:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: short-term convalescent
  BG4-25:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1016/j.cell.2021.04.032
  COVOX-253H165L:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2021.02.032
  CV07-287:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2020.09.049
  C597:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-021-03207-w
  CA521:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s42003-021-02029-w
  REGN10933:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1126/science.abd0831
    alias: casirivimab
  BD-319:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD-833:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  COV2-2684:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  CV07-209:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2020.09.049
  CV-X2-106:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2020.09.049
  BD-922:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: vaccine
  15033:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.jmb.2021.167177
  BD-417:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD55-1508:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  BD-805:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: vaccine
  BG1-24:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2021.04.032
  C083:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-021-03207-w
  COV2-2941:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1038/s41591-020-0998-x
  BD-623:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  COV2-2196:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1038/s41564-021-00972-2
    alias: AZD8895
  COV2-2072:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1038/s41591-020-0998-x
  BD-836:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: long-term convalescent
  COV2-2381:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1038/s41591-020-0998-x
  S2E12:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1126/science.abe3354
  COVOX-253H55L:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1016/j.cell.2021.02.032
  BD-566:
    type: antibody
    subtype: class 1
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: short-term convalescent
  BG10-19:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2021.04.032
  BD55-1274:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  COV2-2353:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  BD55-1694:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  C002:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-020-2456-9
  P17:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41422-020-00444-y
  2-15:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-020-2571-7
  BD-254:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD-362:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD-368:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD-397:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD-403:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  DXP-593:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD55-1579:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  BD-791:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: vaccine
  BD-870:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  BD55-4382:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BG7-20:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2021.04.032
  C591:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-021-03207-w
  CM32:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1126/science.abg5268
  COV2-2064:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  COV2-2504:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  COV2-2539:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  COVA2-39:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1126/science.abc5902
  COVOX-316:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2021.02.032
  COVOX-384:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2021.02.032
  CV05-163:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2020.09.049
  CV07-255:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2020.09.049
  DH1173:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  DH1184:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  H4:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.celrep.2021.108950
  P2B-2F6:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-020-2380-z
  P2C-1A3:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-020-2380-z
  S2H13:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2020.09.037
  S2M11:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1126/science.abe3354
  BD-790:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: vaccine
  C058:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-021-03207-w
  COV2-2391:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  COV2-2479:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  COV2-2955:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  CV07-200:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2020.09.049
  CV07-222:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2020.09.049
  CV07-262:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2020.09.049
  CV07-283:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2020.09.049
  CV07-315:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2020.09.049
  DH1041:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2021.06.021
  DH1042:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  DH1043:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  DH1111:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  DH1159-2:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  DH1186:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  DH1214:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  LY-CoV555:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1126/scitranslmed.abf1906
    alias: bamlanivimab
  BD-536:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD-900:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  C121:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-020-2456-9
  BD55-1962:
    type: antibody
    subtype: class 2
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: long-term convalescent
  1-57:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-020-2571-7
  BD-817:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  BG7-15:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2021.04.032
  C119:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-020-2456-9
  COV2-2499:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  REGN10987:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1126/science.abd0831
    alias: imdevimab
  COVOX-75:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2021.02.032
  COV2-2268:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  Ehling_mAb-50:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2021.02.12.430940
  TAU-2230:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1371/journal.ppat.1009165
  BD55-3457:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD-643:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: vaccine
  BD-918:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: vaccine
  COV2-2780:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  DH1160:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  DH1161-2:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  CV07-270:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1016/j.cell.2020.09.049
  BD-864:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  BD-824:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  BD-812:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  BD-804:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: vaccine
  COV2-2130:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1038/s41564-021-00972-2
    alias: AZD1061
  LY-CoV1404:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1101/2021.04.30.442182
    alias: bebtelovimab
  BD55-1706:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: long-term convalescent
  BD55-387:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: vaccine
  BD55-1104:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: long-term convalescent
  BD-467:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: short-term convalescent
  DH1151:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  BD55-1403:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent double positive
  BD55-3149:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD55-3433:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: SARS convalescent
  BD55-3440:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD55-3451:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD55-4281:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD55-5382:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD55-3546:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD55-5195:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD55-5228:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD55-3637:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: SARS convalescent
  BD55-4285:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  C110:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-020-2456-9
  BD-748:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: vaccine
  BD55-3152:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: SARS convalescent
  BD-744:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: vaccine
  BD55-5386:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: SARS convalescent
  BD-932:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: vaccine
  BD-914:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: long-term convalescent
  BD-713:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: vaccine
  BD-796:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: vaccine
  BD-923:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: vaccine
  BD-907:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: long-term convalescent
  S309:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1038/s41586-020-2349-y
    alias: VIR-7831
  BD55-5319:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: SARS convalescent
  C576:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1038/s41586-021-03207-w
  DH1044:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1101/2020.12.31.424729
  C581:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1038/s41586-021-03207-w
  C556:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1038/s41586-021-03207-w
  DH1193:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1101/2020.12.31.424729
  BD-815:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: long-term convalescent
  BD55-4325:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  COV2-2389:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  BD55-3525:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: SARS convalescent
  BD55-1294:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  BD55-1831:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: long-term convalescent
  BD-913:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  BD-692:
    type: antibody
    subtype: class 3
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: vaccine
  BD55-3716:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD55-5233:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD55-5333:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD-702:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: vaccine
  C594:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41586-021-03207-w
  BD-449:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD-899:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  BD55-5170:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD55-5384:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  COV2-2015:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  COV2-2678:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  BD55-5276:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD55-5325:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD55-5365:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  S304:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1038/s41586-020-2349-y
  COV2-2103:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1038/s41591-020-0998-x
  BD-494:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: short-term convalescent
  BD55-5300:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: SARS convalescent
  BD55-3372:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: SARS convalescent
  BD55-3500:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: SARS convalescent
  BD55-5339:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD55-1237:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: long-term convalescent
  COVA1-16:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: DOI 10.1126/science.abc5902
  BD-801:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: vaccine
  BD55-5259:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  COV2-2828:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1038/s41591-020-0998-x
  DH1047:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
  BD55-5226:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD55-5267:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: SARS convalescent
  BD-708:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: vaccine
  BD55-3304:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-1 then SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1, Omicron BA.1]
    notes: SARS convalescent
  DH1045:
    type: antibody
    subtype: class 4
    year: 2021
    eliciting_virus: SARS-CoV-2
    known_to_neutralize: [Wuhan-Hu-1]
    notes: DOI 10.1101/2020.12.31.424729
